Skip to main content
Clinical Trials/ISRCTN29594895
ISRCTN29594895
Active, not recruiting
未知

A randomised feasibility study evaluating the effect of perioperative intravenous lIdocaine on colorectal cancer outcome after surgery

Chelsea and Westminster Hospital0 sites50 target enrollmentApril 6, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Colorectal cancer patient undergoing surgery for cancer resection
Sponsor
Chelsea and Westminster Hospital
Enrollment
50
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37387798/ (added 03/07/2023)

Registry
who.int
Start Date
April 6, 2022
End Date
September 15, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Chelsea and Westminster Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 18 years and above, undergoing laparoscopic surgery with stage 2 or 3 colon cancer
  • 2\. Ability and willingness to consent

Exclusion Criteria

  • 1\. Stage 1 and stage 4 colon or rectal cancer
  • 2\. Palliative surgery with no curative intent
  • 3\. Extensive comorbidities, i.e. American Society of Anesthesiologists (ASA) Score IV
  • 4\. Patients with known allergy to lidocaine
  • 5\. Patients who are pregnant or breastfeeding
  • 6\. Patients who are likely to have adverse effects from the accumulation of intravenous lidocaine:
  • 6\.1\. Known liver disease with liver function outside the normal laboratory range
  • 6\.2\. Epilepsy
  • 6\.3\. Cardiac conduction abnormalities based on history and confirmed by electrocardiogram

Outcomes

Primary Outcomes

Not specified

Similar Trials